‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply
| dc.contributor.author | Broman Niklas | |
| dc.contributor.author | Feuth Thijs | |
| dc.contributor.author | Oksi Jarmo | |
| dc.contributor.author | COVIDSTORM study group | |
| dc.contributor.organization | fi=keuhkosairausoppi ja kliininen allergologia|en=Pulmonary Diseases and Clinical Allergology| | |
| dc.contributor.organization | fi=sisätautioppi|en=Internal Medicine| | |
| dc.contributor.organization | fi=tyks, vsshp|en=tyks, varha| | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.40502528769 | |
| dc.contributor.organization-code | 1.2.246.10.2458963.20.92467408925 | |
| dc.converis.publication-id | 176385949 | |
| dc.converis.url | https://research.utu.fi/converis/portal/Publication/176385949 | |
| dc.date.accessioned | 2025-08-27T23:54:32Z | |
| dc.date.available | 2025-08-27T23:54:32Z | |
| dc.description.abstract | <p><br></p> | |
| dc.format.pagerange | 1520 | |
| dc.format.pagerange | 1521 | |
| dc.identifier.eissn | 1469-0691 | |
| dc.identifier.jour-issn | 1198-743X | |
| dc.identifier.olddbid | 204843 | |
| dc.identifier.oldhandle | 10024/187870 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/53533 | |
| dc.identifier.url | https://doi.org/10.1016/j.cmi.2022.06.028 | |
| dc.identifier.urn | URN:NBN:fi-fe2023021827707 | |
| dc.language.iso | en | |
| dc.okm.affiliatedauthor | Broman, Niklas | |
| dc.okm.affiliatedauthor | Feuth, Matthijs | |
| dc.okm.affiliatedauthor | Oksi, Jarmo | |
| dc.okm.affiliatedauthor | Dataimport, tyks, vsshp | |
| dc.okm.discipline | 3121 Internal medicine | en_GB |
| dc.okm.discipline | 3121 Sisätaudit | fi_FI |
| dc.okm.internationalcopublication | not an international co-publication | |
| dc.okm.internationality | International publication | |
| dc.okm.type | B1 Scientific Journal | |
| dc.publisher | Elsevier B.V. | |
| dc.publisher.country | United Kingdom | en_GB |
| dc.publisher.country | Britannia | fi_FI |
| dc.publisher.country-code | GB | |
| dc.relation.doi | 10.1016/j.cmi.2022.06.028 | |
| dc.relation.ispartofjournal | Clinical Microbiology and Infection | |
| dc.relation.issue | 11 | |
| dc.relation.volume | 28 | |
| dc.source.identifier | https://www.utupub.fi/handle/10024/187870 | |
| dc.title | ‘Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM’ – Author's reply | |
| dc.year.issued | 2022 |
Tiedostot
1 - 1 / 1